Practical Bayesian Guidelines for Phase IIB Clinical Trials (Q4842831)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Practical Bayesian Guidelines for Phase IIB Clinical Trials |
scientific article; zbMATH DE number 786310
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Practical Bayesian Guidelines for Phase IIB Clinical Trials |
scientific article; zbMATH DE number 786310 |
Statements
Practical Bayesian Guidelines for Phase IIB Clinical Trials (English)
0 references
3 October 1995
0 references
sample size
0 references
phase IIB clinical trial
0 references
informative prior
0 references
decision boundaries
0 references
operating characteristics
0 references
0.8056312203407288
0 references
0.7616724371910095
0 references
0.7606933116912842
0 references
0.7554799914360046
0 references
0.7539166212081909
0 references
